Cargando…
Artemether for severe malaria
BACKGROUND: In 2011 the World Health Organization (WHO) recommended parenteral artesunate in preference to quinine as first‐line treatment for people with severe malaria. Prior to this recommendation many countries, particularly in Africa, had begun to use artemether, an alternative artemisinin deri...
Autores principales: | Esu, Ekpereonne B, Effa, Emmanuel E, Opie, Oko N, Meremikwu, Martin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580442/ https://www.ncbi.nlm.nih.gov/pubmed/31210357 http://dx.doi.org/10.1002/14651858.CD010678.pub3 |
Ejemplares similares
-
Artemether for severe malaria
por: Esu, Ekpereonne, et al.
Publicado: (2014) -
Intermittent screening and treatment with artemether–lumefantrine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria
por: Esu, Ekpereonne, et al.
Publicado: (2018) -
Intermittent preventive treatment for malaria in infants
por: Esu, Ekpereonne B, et al.
Publicado: (2019) -
Intermittent preventive treatment for malaria in infants
por: Esu, Ekpereonne B, et al.
Publicado: (2021) -
Management of Uncomplicated Malaria in Underfives in Private and Public Health Facilities in South-Eastern Nigeria: A Clinical Audit of Current Practices
por: Udoh, Ekong, et al.
Publicado: (2013)